Former Astellas Pharma VP of Biostatistics Joins MMS as Principal Advisor of Biostatistics and Submissions Planning. Dr. Chartier has held positions at Astellas Pharma, Novartis, Wyeth, Pfizer, and United BioSource Corporation across various statistics, biometrics, and biostatistics functions.

DETROIT FREE PRESS NAMES MMS A WINNER OF THE MICHIGAN TOP WORKPLACES 2021 AWARD CANTON, Mich. (11/15/2021) – MMS has been named a 2021 award winner of the Michigan Top Workplaces by the Detroit Free Press Top Workplaces. The award is based solely on employee feedback...

MMS Holdings announced the release of SmartStart™ a Tech-Enabled Templates to reduce time and effort in the document content creation process while increasing the quality of deliverables.

MMS announced today the launch of its pro-bono support program aimed at advancing research for ultra-rare diseases. Within this program, MMS will select from patient advocacy groups with demonstrable need and will provide complimentary regulatory assistance.

Arunima Sen, MD, Director of Pharmacovigilance and Medical Writing (India), has been appointed to the Indian Society of Clinical Research’s Pharmacovigilance Council.

MMS announced that its learning arm, MMS Academy, has expanded its global training portfolio with the launch of new courses in inspection readiness and clinical programming. These new courses – created by industry-trained subject matter experts – will give students and working professionals the opportunity to gain the critical knowledge that the pharmaceutical, biotechnology, and medical device industries require.

MMS has been selected by Health Data Research UK (HDR UK) – the national institute for health data science – as a partner to support the International COVID-19 Data Alliance (ICODA) initiative. MMS was selected from a pool of some of the world’s top clinical research organizations to provide data engineering services to support a globally coordinated, health data-led research response to tackle the COVID-19 pandemic.